Phase 4 Oesophageal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are planned to receive a specific dose of the chemotherapy drug paclitaxel (80 mg/m², given over 1 hour by drip)
- You have had a CT scan, PET-CT scan, or MRI scan (such as of the chest, abdomen, or pelvis, for any reason) within the past year that can be reviewed
- You are female
- You are 18 years old or older
- Your organs (such as liver and kidneys) are functioning well enough to safely receive paclitaxel treatment (confirm with trial site for specific requirements)
- You are able to understand the trial and are willing to sign a consent form
Who may not be able to join:
- You are currently taking certain medications that affect how the body processes paclitaxel, including moderate or strong "inducers" or "inhibitors" of a liver enzyme called CYP2C8 — examples include rifampin (an antibiotic) or clopidogrel (a blood thinner) (confirm with trial site for a full list)
- You have previously had a serious allergic reaction to paclitaxel or any of its ingredients (such as Cremophor EL) that would prevent you from receiving it at the standard dose and infusion length
- You are currently pregnant or breastfeeding
- You are receiving paclitaxel at a different dose or over a different infusion time than specified — for example, due to side effects from a previous treatment cycle or any other reason
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Daniel L Hertz, PharmD, PhD, University of Michigan Rogel Cancer Center
Phone: 800-865-1125
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Maximum concentration (Cmax) of paclitaxel plasma
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.